Feb 28 (Reuters) - GlaxoSmithKline Plc : * Press release: GSK announces submission to U.S. regulatory authorities for
MUMBAI, Feb 10 (Reuters) - GlaxoSmithKline Plc 's (GSK) share tender offer worth $1 billion to raise its stake in the Indian unit will start on Feb 18th and end of March 5th, the manager to the offer said in a notice to the exchanges on Monday.
Feb 5 (Reuters) - GlaxoSmithKline Plc CEO Andrew Witty told reporters: * CEO says European respiratory business remains extremely strong despite
Feb 3 (Reuters) - GlaxoSmithKline Plc : * GSK gains FDA breakthrough therapy designation for Promacta/Revolade (eltrombopag) for severe aplastic anaemia * Designation based on results from study in 43 heavily pretreated patients
Despite growing Advair competition, an improving pipeline sets up Glaxo for steady long-term growth.
SAN FRANCISCO, Jan 21 (Reuters) - GlaxoSmithKline Plc deserves a new trial against Abbott Laboratories because Abbott impermissibly excluded a potential juror based on his sexual orientation, a federal appeals court ruled on Tuesday.
Jan 21 (Reuters) - GlaxoSmithKline Plc : * VIIV Healthcare's new HIV medicine Tivicay Tm (Dolutegravir) is approved in Europe * European commission has approved Tivicaytm
Sept 18 (Reuters) - ChemoCentryx Inc said partner GlaxoSmithKline Plc returned the rights to its inflammatory bowel disease drug, the company's lead product candidate.
WASHINGTON, Sept 10 (Reuters) - A federal advisory panel recommended approval of GlaxoSmithKline Plc 's new drug to treat chronic obstructive pulmonary disease(COPD), but suggested the company be...
WASHINGTON, Sept 10 (Reuters) - An federal advisory panel has recommended that the U.S. Food and Drug Administration approve a drug made by GlaxoSmithKline Plc and Theravance Inc to treat chronic...